TY - JOUR
T1 - Dchs1-fat4 regulation of osteogenic differentiation in mouse
AU - Crespo-Enriquez, Ivan
AU - Hodgson, Tina
AU - Zakaria, Sana
AU - Cadoni, Erika
AU - Shah, Mittal
AU - Allen, Stephen
AU - Al-Khishali, Ayman
AU - Mao, Yaopan
AU - Yiu, Angela
AU - Petzold, Jonna
AU - Villagomez-Olea, Guillermo
AU - Pitsillides, Andrew A.
AU - Irvine, Kenneth D.
AU - Francis-West, Philippa
PY - 2019/7
Y1 - 2019/7
N2 - Mutations of the protocadherins, FAT4 and DCHS1, result in Van Maldergem’s syndrome characterized, in part, by craniofacial abnormalities. Here we analyse the role of Dchs1-Fat4 signalling during osteoblast differentiation. We show that Fat4 and Dchs1 mutants mimic the craniofacial phenotype of the human syndrome and that Dchs1-Fat4 signalling is essential for osteoblast differentiation. In Dchs1/Fat4 mutants, proliferation of osteoprogenitors is increased and osteoblast differentiation is delayed. We show that loss of Dchs1-Fat4 signalling is linked to increased Yap-Tead activity and that Yap is expressed and required for proliferation in osteoprogenitors. In contrast, Taz is expressed in more committed Runx2-expressing osteoblasts, Taz does not regulate osteoblast proliferation and Taz-Tead activity is unaffected in Dchs1/Fat4 mutants. Finally, we show that Yap and Taz differentially regulate the transcriptional activity of Runx2, and that the activity of Yap-Runx2 and that Taz-Runx2 complexes is altered in Dchs1/Fat4 mutant osteoblasts. In conclusion, these data identify Dchs1-Fat4 as a new signaling pathway in osteoblast differentiation, reveal its critical role within the early Runx2 progenitors, and identify distinct requirements for Yap and Taz during osteoblast differentiation.
AB - Mutations of the protocadherins, FAT4 and DCHS1, result in Van Maldergem’s syndrome characterized, in part, by craniofacial abnormalities. Here we analyse the role of Dchs1-Fat4 signalling during osteoblast differentiation. We show that Fat4 and Dchs1 mutants mimic the craniofacial phenotype of the human syndrome and that Dchs1-Fat4 signalling is essential for osteoblast differentiation. In Dchs1/Fat4 mutants, proliferation of osteoprogenitors is increased and osteoblast differentiation is delayed. We show that loss of Dchs1-Fat4 signalling is linked to increased Yap-Tead activity and that Yap is expressed and required for proliferation in osteoprogenitors. In contrast, Taz is expressed in more committed Runx2-expressing osteoblasts, Taz does not regulate osteoblast proliferation and Taz-Tead activity is unaffected in Dchs1/Fat4 mutants. Finally, we show that Yap and Taz differentially regulate the transcriptional activity of Runx2, and that the activity of Yap-Runx2 and that Taz-Runx2 complexes is altered in Dchs1/Fat4 mutant osteoblasts. In conclusion, these data identify Dchs1-Fat4 as a new signaling pathway in osteoblast differentiation, reveal its critical role within the early Runx2 progenitors, and identify distinct requirements for Yap and Taz during osteoblast differentiation.
KW - Dchs1-Fat4
KW - Osteoblast
KW - Runx2
KW - Yap/Taz
UR - http://www.scopus.com/inward/record.url?scp=85070799159&partnerID=8YFLogxK
U2 - 10.1242/dev.176776
DO - 10.1242/dev.176776
M3 - Article
C2 - 31358536
SN - 0950-1991
VL - 146
JO - Development (Cambridge)
JF - Development (Cambridge)
IS - 14
M1 - dev176776
ER -